VGNT · Insider Trading
Versigent PLC
Every open-market purchase and sale reported by VGNT officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-09 | Kevin P Clark | Director | Sell | −97,278 | −$4.35M |
| 2026-09-22 | Brad M Cerepak | Director | A | +14 deriv. | — |
| 2026-09-22 | Janis N Acosta | CLO and Secretary | A | +113 deriv. | — |
| 2026-09-22 | Sharon Vinci | Chief People Officer | A | +172 deriv. | — |
| 2026-09-22 | Eric Kueppers | Director | A | +14 deriv. | — |
| 2026-09-22 | Paul M Meister | Director | A | +14 deriv. | — |
| 2026-09-22 | Amy E Alving | Director | A | +14 deriv. | — |
| 2026-09-22 | Jason Celian | Chief Accounting Officer | A | +25 deriv. | — |
| 2026-09-22 | Kevin P Clark | Director | A | +14 deriv. | — |
| 2026-09-22 | Douglas R Ostermann | Chief Financial Officer | A | +480 deriv. | — |
| 2026-09-22 | Armando Tamez | Director | A | +14 deriv. | — |
| 2026-09-22 | Joseph T. Liotine | CEO and Director | A | +489 deriv. | — |
| 2026-09-10 | Kevin P Clark | Director | Sell | −122,722 | −$5.72M |
| 2026-06-23 | Joseph T. Liotine | CEO and Director | F | −21,289 | −$976.95K |
| 2026-04-24 | Paul M Meister | Director | A | +5,168 | — |
| 2026-04-24 | Amy E Alving | Director | A | +5,168 | — |
| 2026-04-24 | Armando Tamez | Director | A | +5,168 | — |
| 2026-04-24 | Eric Kueppers | Director | A | +5,168 | — |
| 2026-04-24 | Brad M Cerepak | Director | A | +5,168 | — |
| 2026-04-24 | Joseph T. Liotine | CEO and Director | A | +111,698 | — |
| 2026-04-24 | Douglas R Ostermann | Chief Financial Officer | A | +43,438 | — |
| 2026-04-24 | Jason Celian | Chief Accounting Officer | A | +6,982 | — |
| 2026-04-24 | Janis N Acosta | CLO and Secretary | A | +39,871 | — |
| 2026-04-24 | Sharon Vinci | Chief People Officer | A | +18,617 | — |
| 2026-04-24 | Kevin P Clark | Director | A | +5,168 | — |
| 2026-04-06 | Joseph T. Liotine | Chief Executive Officer | A | +109,714 | — |
| 2026-04-06 | Jason Celian | Chief Accounting Officer | A | +2,103 | — |
| 2026-04-06 | Douglas R Ostermann | Chief Financial Officer | A | +126,104 | — |
| 2026-04-06 | Sharon Vinci | Chief People Officer | A | +42,283 | — |
| 2026-04-01 | Aptiv PLC | 10%+ Owner | J | −70,893,660 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Joseph T. Liotine | CEO and Director | 208,864 | $8.66M |
| Douglas R Ostermann | Chief Financial Officer | 169,542 | $7.03M |
| Kevin P Clark | Director | 75,332 | $3.13M |
| Sharon Vinci | Chief People Officer | 61,474 | $2.55M |
| Janis N Acosta | CLO and Secretary | 39,871 | $1.65M |
| Paul M Meister | Director | 11,561 | $479.61K |
| Jason Celian | Chief Accounting Officer | 9,335 | $387.26K |
| Brad M Cerepak | Director | 5,168 | $214.39K |
| Amy E Alving | Director | 5,168 | $214.39K |
| Armando Tamez | Director | 5,168 | $214.39K |
| Eric Kueppers | Director | 5,168 | $214.39K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the VGNT quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.